These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Molecular heterogeneity of hCG in urine of the patients with trophoblastic diseases]. Kitajima T, Mochizuki M, Nishimura R. Nihon Sanka Fujinka Gakkai Zasshi; 1991 Mar; 43(3):297-303. PubMed ID: 1710641 [Abstract] [Full Text] [Related]
4. Detection of hCG in trophoblastic disease. The USA hCG reference service experience. Cole LA, Butler S. J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011 [Abstract] [Full Text] [Related]
8. Use of an immunoradiometric assay and a radioimmunoassay for the detection of free beta-human chorionic gonadotropin. Shapiro AI, Wu TF, Ballon SC, Lamb EJ. Obstet Gynecol; 1985 Apr; 65(4):545-9. PubMed ID: 2580254 [Abstract] [Full Text] [Related]
10. [Fragments of human chorionic gonadotropin (hCG): diagnosis of pregnancy and tumors]. Lechner O, Dirnhofer S, Gerth R, Merz WE, Wick G, Berger P. Wien Klin Wochenschr; 1995 Apr; 107(1):15-9. PubMed ID: 7871785 [Abstract] [Full Text] [Related]
11. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease]. Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J. Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299 [Abstract] [Full Text] [Related]
12. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer. Cole LA, Sutton JM. J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826 [Abstract] [Full Text] [Related]
13. Evaluation of beta-subunit chorionic gonadotropin as an aid in diagnosis of trophoblastic disease. Skinner MS, Seckinger D. Ann Clin Lab Sci; 1979 Jul; 9(4):347-52. PubMed ID: 225983 [Abstract] [Full Text] [Related]
14. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies. O'Connor JF, Schlatterer JP, Birken S, Krichevsky A, Armstrong EG, McMahon D, Canfield RE. Cancer Res; 1988 Mar 01; 48(5):1361-6. PubMed ID: 2449279 [Abstract] [Full Text] [Related]
15. [Detection of hCG production in trophoblastic diseases by HCG beta carboxyl-terminal peptide]. Shimizu T, Matsuura S, Mochizuki M. Nihon Sanka Fujinka Gakkai Zasshi; 1983 Oct 01; 35(10):1759-66. PubMed ID: 6195275 [Abstract] [Full Text] [Related]
16. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin. Than GN, Csaba IF, Bohn H, Szabó DG, Szalmásy M, Menczer G. Oncodev Biol Med; 1982 Oct 01; 3(4):315-23. PubMed ID: 6291007 [Abstract] [Full Text] [Related]
18. [Gestational trophoblast tumors--rare, but important in general practice]. Ebeling K, Schönborn I, Johannsmeyer D. Z Arztl Fortbild (Jena); 1994 Oct 01; 88(10):773-8. PubMed ID: 7529957 [No Abstract] [Full Text] [Related]
19. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases. Shaarawy M, el-Shobokshy AS, el-Noury AI. Cytokine; 1995 Feb 01; 7(2):171-5. PubMed ID: 7540057 [Abstract] [Full Text] [Related]
20. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer]. Nishimura R, Kobayashi K, Katsuno M, Kobayashi T. Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb 01; 42(2):143-8. PubMed ID: 1690253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]